ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

THTX Theratechnologies Inc

1.36
-0.02 (-1.45%)
Apr 24 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Theratechnologies Inc THTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.02 -1.45% 1.36 20:00:00
Open Price Low Price High Price Close Price Prev Close
1.38 1.32 1.42 1.36 1.38
more quote information »

Recent News

Date Time Source Heading
4/15/202416:15GLOBETheratechnologies Announces Mailing of Management Proxy..
4/11/202407:30GLOBETheratechnologies to Present at the 2024 Bloom Burton & Co...
4/10/202407:30GLOBETheratechnologies Reports Financial Results and Provides..
4/10/202407:15IHMARKETNEWSU.S. Index Futures Show Mixed Trend Ahead of Key Inflation..
4/08/202416:30GLOBETheratechnologies Preclinical Data Presentation at AACR 2024..
4/05/202411:00GLOBETheratechnologies Appoints Elina Tea to its Board of..
4/03/202407:30GLOBETheratechnologies to Announce First Quarter 2024 Financial..
3/28/202407:30GLOBETheratechnologies to Present Preclinical Data at AACR on..
3/22/202409:36GLOBETheratechnologies Announces Update on its Preclinical..
3/21/202420:00GLOBETheratechnologies Appoints Jordan Zwick to its Board of..
3/21/202407:30GLOBETheratechnologies Initiates Increased Dose Level in Phase 1..
2/29/202416:55EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/29/202416:34GLOBETheratechnologies Announces the Resignation of One of Its..
2/27/202408:37EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/27/202407:30GLOBETheratechnologies Receives Refusal to File Letter for..
2/21/202408:01EDGAR2Form 20-F - Annual and transition report of foreign private..
2/21/202408:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/21/202407:30GLOBETheratechnologies Reports Financial Results for the Fourth..
2/20/202407:30GLOBETheratechnologies Announces Publication in Frontiers in..
2/15/202408:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/15/202407:30GLOBETheratechnologies Completes Enrollment of First Six Patients..
2/06/202414:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/06/202407:30GLOBETheratechnologies to Announce Fourth Quarter and Full Year..
2/01/202411:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/24/202413:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/24/202407:00GLOBETheratechnologies Receives Complete Response Letter (CRL)..
1/23/202414:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/23/202407:30GLOBETheratechnologies Receives Update from FDA on Tesamorelin F8..
1/04/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
1/02/202416:28EDGAR2Form F-3/A - Registration statement by foreign private..
1/02/202409:00APSWill This Dual-Listed Bio-Pharma Catch New Year Action?
1/02/202407:30GLOBETheratechnologies Submits sBLA for Trogarzo® Intramuscular..
12/21/202316:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/21/202316:12PRNCATheratechnologies annonce le renouvellement de son..
12/21/202316:09PRNUSTheratechnologies Announces Renewal of Shelf Prospectus and..
12/21/202313:21EDGAR2Form F-3 - Registration statement by foreign private issuers
12/13/202314:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/13/202307:30GLOBETheratechnologies Announces FDA Approval of Trogarzo®..
11/28/202316:52EDGAR2Form SC 13D - General statement of acquisition of beneficial..
11/24/202307:30GLOBETheratechnologies Receives 2023 CQDM ADRIQ RSRI Innovation..
11/06/202313:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/06/202312:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/03/202314:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/31/202312:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/31/202312:34GLOBETheratechnologies Announces Closing of US$25 Million Public..
10/26/202321:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/26/202309:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/26/202308:00GLOBETheratechnologies Announces Pricing of US$25 Million Public..
10/25/202316:13GLOBETheratechnologies Announces Proposed Public Offering of..
10/24/202314:46EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Your Recent History

Delayed Upgrade Clock